Wall Street brokerages predict that Nutrien Ltd (NYSE:NTR) will announce $3.71 billion in sales for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Nutrien’s earnings. The highest sales estimate is $4.09 billion and the lowest is $3.24 billion. Nutrien posted sales of $3.76 billion in the same quarter last year, which suggests a negative year-over-year growth rate of 1.3%. The firm is scheduled to report its next earnings report on Wednesday, February 5th.
According to Zacks, analysts expect that Nutrien will report full-year sales of $19.80 billion for the current fiscal year, with estimates ranging from $19.05 billion to $20.57 billion. For the next year, analysts anticipate that the firm will report sales of $21.38 billion, with estimates ranging from $19.74 billion to $23.57 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that follow Nutrien.
Nutrien (NYSE:NTR) last released its quarterly earnings results on Monday, November 4th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.12). The firm had revenue of $4.13 billion for the quarter, compared to analysts’ expectations of $4.02 billion. Nutrien had a return on equity of 6.49% and a net margin of 20.95%. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.47 EPS.
A number of research analysts recently issued reports on NTR shares. Raymond James set a $65.00 price target on Nutrien and gave the stock a “strong-buy” rating in a research note on Wednesday, November 6th. Consumer Edge assumed coverage on Nutrien in a research note on Monday, September 23rd. They issued an “overweight” rating and a $67.00 target price on the stock. Berenberg Bank reiterated a “hold” rating and issued a $50.00 target price on shares of Nutrien in a research note on Wednesday, November 6th. TD Securities lowered their target price on Nutrien from $69.00 to $67.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Finally, Scotiabank set a $60.00 target price on Nutrien and gave the company a “buy” rating in a research note on Thursday, September 26th. Five equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $60.53.
Institutional investors have recently bought and sold shares of the stock. LS Investment Advisors LLC purchased a new stake in shares of Nutrien in the second quarter valued at approximately $27,000. Bessemer Group Inc. boosted its stake in shares of Nutrien by 354.4% in the second quarter. Bessemer Group Inc. now owns 727 shares of the company’s stock valued at $39,000 after buying an additional 567 shares in the last quarter. Liberty Wealth Management LLC boosted its stake in shares of Nutrien by 340.5% in the second quarter. Liberty Wealth Management LLC now owns 740 shares of the company’s stock valued at $40,000 after buying an additional 572 shares in the last quarter. First Interstate Bank boosted its stake in shares of Nutrien by 470.6% in the third quarter. First Interstate Bank now owns 970 shares of the company’s stock valued at $48,000 after buying an additional 800 shares in the last quarter. Finally, Coastal Investment Advisors Inc. boosted its stake in shares of Nutrien by 63.8% in the second quarter. Coastal Investment Advisors Inc. now owns 929 shares of the company’s stock valued at $49,000 after buying an additional 362 shares in the last quarter. Hedge funds and other institutional investors own 65.00% of the company’s stock.
NYSE:NTR traded up $0.41 during mid-day trading on Friday, reaching $46.65. 1,015,440 shares of the stock were exchanged, compared to its average volume of 1,497,916. The company has a 50 day simple moving average of $48.42 and a 200-day simple moving average of $50.36. The stock has a market capitalization of $27.17 billion, a P/E ratio of 17.34, a P/E/G ratio of 2.61 and a beta of 0.89. The company has a quick ratio of 0.77, a current ratio of 1.28 and a debt-to-equity ratio of 0.41. Nutrien has a 1 year low of $43.96 and a 1 year high of $56.00.
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
Featured Story: What is the price-to-earnings growth (PEG) ratio?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.